Search results

General manager ANSTO Communications and Stakeholder Engagement was one of the presenters at the IAEA W4NSEC workshop

Since 1962, the United Uranium Scholarship has helped promising young scientists in the field of nuclear energy extend their knowledge and expertise. In 2022, scholarships were awarded to several ANSTO researchers, including Phil Sutton.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

ANSTO researchers contribute to study which finds evidence of Aboriginal occupation 65,000 years ago in Northern Australia.

ANSTO has a range of capabilities and expertise to support aerospace and space research.

Griffith University researchers are conducting an experiment at ANSTO that will test a revolutionary physics theory that time reversal symmetry-breaking by neutrinos might cause a time dilation at the quantum scale.

Defence requirements push your technology, we can help. ANSTO is home to some of Australia’s most important landmark research infrastructure – more than $1.3bn of it.  Our unique capabilities are used by thousands of Australian researchers from industry and academia every year.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

ANSTO Publications Online is a digital repository for publications authored by ANSTO staff and collaborators since 1956.

View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.

International interest is building in Australia’s new multi-million-dollar radioactive waste processing facility at the Sydney campus of the Australian Nuclear Science and Technology Organisation (ANSTO).

ANSTO continually monitors environmental gamma radiation from a station located in Engadine NSW. ANSTO uses environmental radiation data to evaluate atmospheric dispersion from its site. This radiation is almost completely natural background radiation.

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

The Hungarian Ambassador to Australia and a small delegation visited ANSTO for a special ceremony to mark the installation and commissioning of two new nuclear medicine scanners from the Hungarian company Mediso Pacific.

A pioneering study led by Professor Junpei Yamanaka of Nagoya City University and an international team that included ANSTO has delivered transformative insights into the behaviour of colloidal particles under microgravity.